Literature DB >> 17323842

Nitric oxide-dependent endothelial function and cardiovascular disease.

F Desjardins1, J L Balligand.   

Abstract

Nitric oxide produced by three different isoforms of nitric oxide synthase (NOS) widely expressed in virtually all vascular cell types is mostly produced by the endothelial isoform (eNOS) in endothelial cells where it plays a crucial role in vascular tone and structure regulation. It also exerts an anti-inflammatory influence, inhibits platelets adhesion and aggregation, and prevents smooth muscle cells proliferation and migration. Several lines of evidence link endothelial dysfunction, characterized by decreased bioavailability of nitric oxide, with the development of many pathological conditions such as heart failure, hypertension, diabetes and atherosclerosis. This review focuses on nitric oxide-dependent endothelial dysfunction in cardiovascular diseases, its clinical detection and relevance, potential pathogenic mechanisms and possible therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17323842     DOI: 10.1179/acb.2006.052

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  23 in total

Review 1.  Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders.

Authors:  Pitchai Balakumar; Sonam Kathuria
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 2.  Interaction between nitric oxide signaling and gap junctions: effects on vascular function.

Authors:  R C Looft-Wilson; M Billaud; S R Johnstone; A C Straub; B E Isakson
Journal:  Biochim Biophys Acta       Date:  2011-07-28

3.  c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow.

Authors:  Bochuan Li; Jinlong He; Huizhen Lv; Yajin Liu; Xue Lv; Chenghu Zhang; Yi Zhu; Ding Ai
Journal:  J Clin Invest       Date:  2019-02-11       Impact factor: 14.808

Review 4.  HBOC vasoactivity: interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide species.

Authors:  Pedro Cabrales; Joel M Friedman
Journal:  Antioxid Redox Signal       Date:  2013-02-12       Impact factor: 8.401

5.  Elevations in time-varying resting heart rate predict subsequent all-cause mortality in older adults.

Authors:  Bríain ó Hartaigh; Heather G Allore; Mark Trentalange; Gail McAvay; Stefan Pilz; John A Dodson; Thomas M Gill
Journal:  Eur J Prev Cardiol       Date:  2014-01-20       Impact factor: 7.804

6.  Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.

Authors:  Sonam Kathuria; Nanjaian Mahadevan; Pitchai Balakumar
Journal:  Mol Cell Biochem       Date:  2012-11-10       Impact factor: 3.396

7.  FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.

Authors:  Haifeng Ni; Junfeng Chen; Mingming Pan; Minghui Zhang; Jiandong Zhang; Pingsheng Chen; Bicheng Liu
Journal:  J Mol Histol       Date:  2013-08-02       Impact factor: 2.611

8.  Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease.

Authors:  Jeff S Isenberg; Martin J Romeo; Justin B Maxhimer; Jeremy Smedley; William A Frazier; David D Roberts
Journal:  Ann Surg       Date:  2008-05       Impact factor: 12.969

9.  Changes in the level of cytosolic calcium, nitric oxide and nitric oxide synthase activity during platelet aggregation: an in vitro study in platelets from normal subjects and those with cirrhosis.

Authors:  Sam Annie-Jeyachristy; Arumugam Geetha; Rajagopal Surendran
Journal:  J Biosci       Date:  2008-03       Impact factor: 1.826

10.  Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice.

Authors:  Xizhen Xu; Chun Xia Zhao; Luyun Wang; Ling Tu; Xiaosai Fang; Changlong Zheng; Matthew L Edin; Darryl C Zeldin; Dao Wen Wang
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.